Close Menu


Affymetrix has introduced its GeneChip CustomExpress program, which allows customers to design low-density arrays of 1,000 probes or less using GeneChip probe sets and the same chip manufacturing system as the GeneChip system.

Affymetrix has made several management changes. Robert Ellis, former CEO of Genometrix, which closed its doors June 25, is the company’s new vice president, product development and quality.

AT A GLANCE Master''s in biology from New York University, 2000 Enjoys bicycling to work from his home in the Bronx, and swimming. Qualified for the 1996 US Olympic Swim Team. Opened Rockefeller University’s GeneArray facility in June 2000.

Dutch microarray maker PamGene has been awarded $3 million in two government grants for research and development on its flow-through PamChip, and has signed a four-year joint research agreement with Erasmus University in Rotterdam, the Netherlands, to study gene expression in osteoporosis and osteoarthritis.

Protein chip maker Zyomyx of Hayward, Calif., has entered into an agreement for access to BD Biosciences antibody collection, Zyomyx said.

GeneMachines has sold two OmniGrid microarrayers to the Genome Institute of Singapore, a new research institute that comprises part of the country s promised $4 billion investment in genomics and biotechnology.

Need to order a custom-designed oligonucleotide array at 3AM? Now Affymetrix customers can do just that, with a new CustomExpress program and the company s NetAffx website.

With market leader Affymetrix rebounding from a slide, and a slew of product development projects and collaborations, quarterly earnings reports largely indicate that the microarray and biochip sector is continuing to grow rapidly.

PATENT WATCH: Jul 27, 2001


GeneMachines Licenses Microarray Fabrication Technology from Incyte



Stephen Johnson, an assistant professor in the department of pharmacology at the University of Pennsylvania, has launched a website in which researchers, especially microarray researchers who want to quickly validate their data, can s


In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.